Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,215 | -21,900 | -23,654 | -26,601 | -24,322 |
| Depreciation Amortization | 447 | 420 | 51 | 56 | 78 |
| Other Working Capital | -1,103 | -1,277 | 1,234 | 1,802 | 1,688 |
| Other Operating Activity | 1,254 | 1,295 | 1,799 | 3,190 | 1,767 |
| Operating Cash Flow | $-21,617 | $-21,462 | $-20,571 | $-21,553 | $-20,789 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -253 | -64 | -96 | -25 | -60 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -50 |
| Investing Cash Flow | $-253 | $-64 | $-96 | $-25 | $-110 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -460 | -322 | N/A | N/A | -266 |
| Common Stock Issued | 76,636 | 17,436 | 16,981 | 18,815 | 16,041 |
| Financing Cash Flow | $76,176 | $17,114 | $16,981 | $18,815 | $15,775 |
| Beginning Cash Position | 9,693 | 14,105 | 17,791 | 20,554 | 25,678 |
| End Cash Position | 63,999 | 9,693 | 14,105 | 17,791 | 20,554 |
| Net Cash Flow | $54,306 | $-4,412 | $-3,686 | $-2,764 | $-5,124 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,617 | -21,462 | -20,571 | -21,553 | -20,789 |
| Capital Expenditure | -253 | -64 | -96 | -25 | -60 |
| Free Cash Flow | -21,870 | -21,526 | -20,667 | -21,578 | -20,849 |